{"Symbol": "ASBP", "AssetType": "Common Stock", "Name": "Aspire BioPharma, Inc.", "Description": "Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.", "CIK": "1847345", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "23150 FASHION DRIVE, ESTERO, FL, UNITED STATES, 33928", "OfficialSite": "https://aspirebiolabs.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "6849700", "EBITDA": "None", "PERatio": "None", "PEGRatio": "None", "BookValue": "-9.26", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-25.66", "RevenuePerShareTTM": "0.002", "ProfitMargin": "0", "OperatingMarginTTM": "-590.16", "ReturnOnAssetsTTM": "-1.951", "ReturnOnEquityTTM": "0", "RevenueTTM": "1941", "GrossProfitTTM": "884", "DilutedEPSTTM": "-25.66", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "None", "AnalystRatingStrongBuy": "-", "AnalystRatingBuy": "-", "AnalystRatingHold": "-", "AnalystRatingSell": "-", "AnalystRatingStrongSell": "-", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "3528.95", "PriceToBookRatio": "-", "EVToRevenue": "6968.66", "EVToEBITDA": "-", "Beta": "0.813", "52WeekHigh": "394.4", "52WeekLow": "1.2", "50DayMovingAverage": "3.063", "200DayMovingAverage": "11.2", "SharesOutstanding": "4790000", "SharesFloat": "2331900", "PercentInsiders": "10.838", "PercentInstitutions": "4.603", "DividendDate": "None", "ExDividendDate": "None"}